Publications by authors named "Brenda M Dias"
Pharmaceuticals (Basel)
September 2023
Article Synopsis
- Bovine lactoferrin (bLf) exhibits significant antiviral activity against SARS-CoV-2, including the omicron variant, potentially providing a new therapeutic option.
- Both unsaturated (apo-bLf) and saturated (holo-bLf) forms reduced virus infection by around 70% when present during infection, with effectiveness peaking in the early stages of infection.
- Holo-bLf showed slightly better efficacy in preventing virus entry compared to apo-bLf, indicating that bLf could be a promising treatment for COVID-19 due to its low toxicity and significant inhibitory effects.
